Nanose Medical develops non-invasive diagnostic tools utilizing nanotechnology and machine learning to screen for diseases using breath biomarkers. Their portable handheld device provides rapid, accurate results for early disease detection and remote patient management. This technology aims to improve outcomes for chronic conditions and cancers like liver disease and lung cancer.
Funding
$642.3K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current diagnostic methods for lung cancer and liver disease often detect the conditions late, reducing treatment effectiveness. Traditional methods can be invasive, costly, and require specialized equipment, limiting accessibility and hindering early intervention.
Solution
NaNose Medical is developing a breathomics platform that uses nanotechnology and artificial intelligence to detect diseases at an early stage through non-invasive breath analysis. The platform analyzes volatile organic compounds (VOCs) in exhaled breath to create unique "breath fingerprints" indicative of specific diseases. This approach offers a portable, user-friendly, and cost-effective solution for early disease screening and patient stratification. The "DiaNose" breath test aims to provide healthcare systems with a tool for earlier identification of liver disease and timely specialist care, while the LUCIA project focuses on improving early detection and management of lung cancer through in-depth risk factor analysis.
Target Audience
The primary target audience includes healthcare providers, general practitioners, and specialists focused on early disease detection and management of lung cancer and liver disease.
Features
- Nanotechnology-based sensors for detecting volatile biomarkers in breath
- AI-driven analysis to create disease-specific breath fingerprints
- Non-invasive and simple to use, reducing dependency on user skill
- Portable handheld device for point-of-care diagnostics
- Rapid results for timely intervention
- High accuracy in disease detection
- Cost-effective solution for mass screening